https://www.aoa.org/about-the-aoa/press-room/statements/aoa-statement-to-fda-on-low-dose-atropine
The American Optometric Association (AOA) acknowledges the Food and Drug Administration's (FDA) responsibility to ensure the safety and effectiveness of...
aoastatementfdalowdose
https://pubmed.ncbi.nlm.nih.gov/39400089/
0.01% atropine was effective in slowing the progression of myopia in the treated group vs. control one. The clinical effect was noticeable already from the...
treatmentprogressivemyopiaatropinechildren
https://www.technologynetworks.com/drug-discovery/news/trial-shows-low-dose-atropine-eye-drops-no-better-than-placebo-at-slowing-nearsightedness-in-376162
Use of low-dose atropine eyedrops was no better than placebo at slowing myopia progression and elongation of the eye among children treated for two years,...
eye dropsno bettertrialshowslow